Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia Correlates with Clinical Features and Treatment Outcome

References

• Crist W. M., Carroll A. J., Shuster J. J., Behm F. G., Whitehead M., Vietti T. J., Look A. T., Mahoney D., Ragab A., Pullen D. J., Land V. J. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13). A Pediatric Oncology Group Study. Blood 1990; 76: 117–122
   PubMed Web of Science ®Google Scholar
• Crist W., Carroll A., Shuster J., Jackson J., Head D., Borowitz M., Behm F., Link M., Steuber P., Ragab A., Hirt A., Brock B., Land V., Pullen J. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group (POG) Study. Blood 1990; 76: 489–494
   PubMed Web of Science ®Google Scholar
• Rivera G. K., Raimondi S. C., Hancock M. L., Behm F. G., Pui C.-H., Abromowitch M., Mirro J., Jr, Ochs J. S., Look A. T., Williams D. L., Murphy S. B., Dahl G. V., Kalwinsky D. K., Evans W. E., Kun L. E., Simone J. V., Crist W. M. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61–66
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Crist W. M., Look A. T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449–1463
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Crist W. M. Chromosomal abnormalities in childhood acute lymphoblastic leukemia. Recent Advances in Hematology 6. Churchill Livingstone, Edinburgh
   Google Scholar
• Pui C.-H., Williams D. L., Raimondi S. C., Rivera G. K., Look A. T., Dodge R. K., George S. L., Behm F. G., Crist W. M., Murphy S. B. Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1987; 70: 247–253
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Williams D. L., Roberson P. K., Raimondi S. C., Behm F. G., Lewis S. H., Rivera G. K., Kalwinsky D. K., Abromowitch M., Crist W. M., Murphy S. B. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 1988; 6: 56–61
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Behm F. G., Roberson P. K., Pui C.-H., Rivera G. K., Murphy S. B., Williams D. L. Cytogenetics of childhood T-cell leukemia. Blood 1988; 72: 1560–1566
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Dodge R. K., Rivera G. K., Fuchs L. A. H., Abromowitch M., Look A. T., Furman W. L., Crist W. M., Williams D. L. Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (50 chromosomes) acute lymphoblastic leukemia. Blood 1989; 73: 1963–1967
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Gajl-Peczalska K. J., Provisor A. J., Heerema N. A. Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood 1989; 73: 271–280
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Carroll A. J., Raimondi S. C., Land V. J., Crist W. M., Shuster J. J., Williams D. L., Pullen D. J., Borowitz M. J., Behm F. G., Look A. T. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid 45 line. Blood 1990; 75: 1170–1177
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Behm F. G., Roberson P. K., Williams D. L., Pui C.-H., Crist W. M., Look A. T., Rivera G. K. Cytogenetics of pre-B acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J. Clin. Oncol. 1990; 8: 1380–1388
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Carroll A. J., Head D., Raimondi S. C., Shuster J. J., Crist W. M., Link M. P., Behm F. G., Land V. J., Nash M., Pullen D. J., Look A. T. Near-triploidy and near-tetraploidy acute lymphoblastic leukemia of childhood. Blood 1990; 76: 590–596
   PubMed Web of Science ®Google Scholar
• Sullivan M. P., Pullen D. J., Crist W. M., Brecher M., Ramirez I., Sabio H., Borowitz M. J., Head D. R., Cerezo L., Shuster J. J., Murphy S. B. Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trials. Leukemia 1990; 4: 6–11
   PubMed Web of Science ®Google Scholar
• Trent J. M., Kaneko Y., Mitelman F. Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet. 1989; 51: 533–562
   PubMedGoogle Scholar
• Williams D. L., Raimondi S. C., Pui C.-H., Rivera G. K. Evolving chromosome patterns and new cytogenetic concepts in childhood acute lymphoblastic leukemia. Acute Lymphoblastic Leukemia: UCLA Symposia on Molecular and Cellular Biology, R. P. Gale, D. Hoelzer. Wiley-Liss, New York 1990; 91–100
   Google Scholar
• Raimondi S. C., Privitera E., Williams D. L., Look A. T., Behm F., Rivera G. K., Crist W. M., Pui C.-H. New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. Blood 1991; 77: 2016–2022
   PubMed Web of Science ®Google Scholar
• Williams D. L., Harber J., Murphy S. B., Look A. T., Kalwinsky D. K., Rivera G., Melvin S. L., Stass S., Dahl G. V. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 1986; 68: 205–212
   PubMed Web of Science ®Google Scholar
• Third International Workshop on Chromosomes in Leukemia. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res. 1983; 43: 868–873
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L. M., Chessells J. M., Stewart E. L., Swansbury G. J., Richards S., Lawler S. D. Chromosomes and other prognostic factors in acute lymphoblastic leukemia: a long-term follow-up. Br. J. Haematol. 1989; 72: 336–342
   PubMed Web of Science ®Google Scholar
• The Third International Workshop on Chromosomes in Leukemia. Cancer Genet. Cytogenet. 1981; 4: 95–142
   Google Scholar
• Prigogina E. L., Puchkova G. P., Mayakova S. A. Nonrandom chromosomal abnormalities in acute lymphoblastic leukemia of childhood. Cancer Genet. Cytogenet. 1988; 32: 183–203
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Roberson P. K., Pui C.-H., Rivera Behm F. G., Hyperdiploid G. K. (47–50) acute lymphoblastic leukemia in children. Blood, in press
   Google Scholar
• Look A. T., Roberson P. K., Willimas D. L., Rivera G., Bowman W. P., Pui C.-H., Ochs J., Abormowitch M., Kalwinsky D., Dahl G. V., George S., Murphy S. B. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985; 65: 1079–1086
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Rowley J. D., Variakojis D., Chilcote R. R., Check I., Sakurai M. Correlation of karyotype with clinical features in acute lymphoblastic leukemia. Cancer Res. 1982; 42: 2918–2929
   PubMed Web of Science ®Google Scholar
• Michael P. M., Garson O. M., Ekert H., Tauro G., Rennie G. C., Pilkington G. R. Prospective study of childhood acute lymphocytic leukemia: hematologic, immunologic, and cytogenetic correlations. Med. Pediatr. Oncol. 1988; 16: 153–161
   PubMedGoogle Scholar
• Bloomfield C. D., Seeker-Walker L. M., Goldman A. I., van den Berghe H., Chapelle A, Ruutu T., Alimena G., Garson O. M., Golomb H. M., Rowley J. D., Kaneko Y., Whang-Peng J., Prigogina E., Philip P., Sandberg A. A., Lawler S. D., Mitelman G. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 1989; 40: 171–185
   PubMed Web of Science ®Google Scholar
• Abe R., Ryan D., Cecalupo A., Cohen H., Sandberg A. A. Cytogenetic findings in congenital leukemia: case report and review of the literature. Cancer Genet. Cytogenet. 1983; 9: 139–144
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Murphy S. B., Ribeiro R. C., Kalwinsky D. K., Dahl G. V., Crist W. M., Williams D. L. An analysis of leukemic cell chromosomal features in infants. Blood 1987; 69: 1289–1293
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Shikano T., Maseki N., Sakurai M., Sakurai M., Takeda T., Hiyoshi Y., Mimaya J.-I., Fujimoto T. Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia 1988; 2: 672–676
   PubMed Web of Science ®Google Scholar
• Ludwig W.-D., Bartram C. R., Harbott J., Koller U., Haas O. A., Hansen-Hagge T., Heil G., Seibl-Jung H., Teichmann J. V., Ritter J., Knapp W., Gadner H., Thiel E., Riehm H. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia 1989; 3: 431–439
   PubMed Web of Science ®Google Scholar
• Stark B., Vogel R., Cohen I. J., Umiel T., Mammon Z., Rechavi G., Kaplinsky C., Potaznik D., Dvir A, Yaniv Y., Goshen Y., Katzir N., Ramot B., Zaizov R. Biologic and cytogenetic characteristics of leukemia in infants. Cancer 1989; 63: 117–125
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Williams D. L. Isochromosome 17q in childhood acute lymphoblastic leukemia: an adverse cytogenetic feature in association with hyperdiploidy?. Leukemia 1988; 2: 222–225
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Carroll A. J., Raimondi S. C., Schell M. J., Head D. R., Shuster J. J., Crist W. M., Borowitz M. J., Link M. P., Behm F. G., Steuber C. P., Land V. J. Childhood acute lymphoblastic leukemia (ALL) with isochromosome. Blood, in press
   Google Scholar
• Behm F. G., Raimondi S. C., Schell M. J., Look A. T., Rivera G. K., Pui C.-H. Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features. Blood, in press
   Google Scholar
• Suchard S. J., Bourguignon L. Y. W. Further characterization of fodrin-containing transmembrane complex from mouse T-lymphoma cells. Biochem. Biophsv. Acta. 1987; 896: 35–46
   PubMed Web of Science ®Google Scholar
• Whitehead V. M., Vuchich M.-J., Carroll A. J., Shuster J. J., Lauer S., Mahoney D., Akabutu J., Bowen T., Beardesley P., Leclerc J.-M., Pullen D. J. Methotrexate metabolism in lymphoblasts with hyperdiploidy and/or translocations in children with acute lymphoblastic leukemia (ALL): a Pediatric Oncology Group Study. Blood 1990; 76: 335a, abstract
   Google Scholar
• Whitehead V. M., Rosenblatt D. S., Vuchich M.-J., Shuster J. J., Witte A., Beaulieu D. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis. Blood 1990; 76: 44–49
   PubMed Web of Science ®Google Scholar
• Stern R., Widirstky S. T., Wurster-Hill D. H., Allen R. D., Smith K. A., Comwell G. G., Cornell C. J. Hand-mirror cell leukemia associated with mental retardation: immunologic, chromosome, and morphological studies. Blood 1979; 54: 703–712
   PubMed Web of Science ®Google Scholar
• Abe R., Raza A., Preisler H. D., Tebbi C. K., Sandberg A. A. Chromosomes and causation of human cancer and leukemia. LIV. Near-tetraploidy in acute leukemia. Cancer Genet. Cytogenet. 1985; 14: 45–59
   PubMed Web of Science ®Google Scholar
• Heerema N. A., Palmer C. G., Baehner R. L. Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. Cancer Genet. Cytogenet. 1985; 17: 165–179
   PubMed Web of Science ®Google Scholar
• Heim S., Alimena G., Billström R., Diverio D., Kristoffers-Son U., Mandahl N., Nanni M., Mitelman F. Tetraploid karyotype (92.XXYY) in two patients with acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 1987; 29: 129–133
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Behm F. G., Singh B., Schell M. J., Williams D. L., Rivera G. K., Kalwinsky D. K., Sandlund J. T., Crist W. M., Raimondi S. C. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 1990; 75: 174–179
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L. M., Lawler S. D., Hardisty R. M. Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis. Br. Med. J. 1978; 2: 1529–1530
   PubMed Web of Science ®Google Scholar
• Swansbury G. J., Seeker-Walker L. M., Lawler S. D., Hardisty R. M., Sallan S. E., Garson O. M., Sakurai M. Chromosomal findings in acute lymphoblastic leukemia of childhood: an independent prognostic factor. Lancet 1981; 2: 249–250
   PubMed Web of Science ®Google Scholar
• Williams D. L., Tsiatis A., Brodeur G. M., Look A. T., Melvin S. L., Bowman W. P., Kalwinsky D. K., Rivera G., Dahl G. V. Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 1982; 60: 864–871
   PubMed Web of Science ®Google Scholar
• Third International Workshop on Chromosomes in Leukemia. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res. 1983; 43: 868–873
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D., Lindquist L. L., Arthur D., McKenna R. W., LeBien T. W., Peterson B. A., Nesbit M. A. Chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Res. 1981; 41: 4838–4843
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Crist W. M. High-risk lymphoblastic leukemia in children: prognostic factors and management. Blood Rev. 1987; 1: 25–33
   PubMedGoogle Scholar
• Fletcher J. A., Kimball V. M., Lynch E., Donnelly M., Pavelka K., Gelber R. D., Tantravahi R., Sallan S. E. Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. Blood 1989; 74: 2130–2135
   PubMed Web of Science ®Google Scholar
• Cleary M. L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 1991; 6: 619–622
   Web of Science ®Google Scholar
• Croce C. M., Nowell P. C. Molecular basis of human B cell neoplasia. Blood 1985; 65: 1–7
   PubMed Web of Science ®Google Scholar
• Kelly K., Cochran B. H., Stiles C. D., Leder P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 1983; 35: 603–610
   PubMed Web of Science ®Google Scholar
• Evan G. I., Hancock D. C. Studies on the interaction of the human c-myc protein with cell nuclei: P62cmyc as a member of a discrete subset of nuclear proteins. Cell 1985; 43: 253–261
   PubMed Web of Science ®Google Scholar
• Blanchard J., Piechaczyk M, Dani C., Chambard J.-C., Franchi A., Pouyssegur J., Jeanteur P. C-myc gene is transcribed at high rate in G0 arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature 1985; 317: 443–445
   PubMed Web of Science ®Google Scholar
• Blackwell T. K., Kretzner L., Blackwood E. M., Eisenman R. N., Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science 1990; 250: 1149–1151
   PubMed Web of Science ®Google Scholar
• Blackwood E. M., Eisenman R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991; 25: 1211–1217
   Web of Science ®Google Scholar
• Adams J. M., Harris A. W., Pinkert C. A., Corcoran L. M., Alexander W. S., Cory S, Palmiter R. D., Brinster R. L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533–538
   PubMed Web of Science ®Google Scholar
• Langdon W. Y., Harris A. W., Cory S., Adams J. M. The c-myc oncogene perturbs B lymphocyte develop ment in Eu-myc transgenic mice. Cell 1986; 47: 1118
   Web of Science ®Google Scholar
• Lombardi L., Newcomb E. W., Dalla-Favera R. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversions of EBV-infected human B lymphoblasts. Cell 1987; 49: 161–170
   PubMed Web of Science ®Google Scholar
• Mellentin J. D., Smith S. D., Cleary M. L. Lyl-1, a novel gene altered by chromosomal translocation in T-cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 1989; 58: 77–83
   PubMed Web of Science ®Google Scholar
• Begley C. G., Apian P. D., Denning S. M., Haynes B. F., Waldmann T. A., Kirsch I. R. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA 1989; 86: 10128–10132
   PubMed Web of Science ®Google Scholar
• Chen Q., Cheng J., Tsai L., Schneider N., Buchanan G., Carroll A., Crist W., Ozanne B., Siciliano M. J., Baer R. The lal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EM BO J. 1990; 9: 415–424
   PubMed Web of Science ®Google Scholar
• Hatano M., Roberts C. W. M., Minden M., Crist W. M., Korsmeyer S. J. Deregulation of a homeobox gene, HOX11, by the t(10; 14) in T-cell leukemia. Science 1991; 253: 79–82
   PubMed Web of Science ®Google Scholar
• Mc Guire E. A., Hockett R. D., Pollock K. M., Bartholdi M. F., O'Brien S. J., Korsmeyer S. J. The t(11;14)(p15;q11)in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol. Cell. Biol. 1989; 9: 2124–2132
   PubMed Web of Science ®Google Scholar
• Boehm T., Greenberg J. M., Buluwela L., Lavenir I., Forster A., Rabbitts T. H. An unusual structure of a putative T-cell oncogene which allows production of similar proteins from distinct mRNAs. EMBO J. 1990; 9: 857–868
   PubMed Web of Science ®Google Scholar
• Greenberg J. M., Boehm T., Sefroniew M. V., Keynes R. J., Barton S. C., Norris M. L., Surani M. A., Spillantini M.-G., Rabbitts T. H. Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system. Nature 1990; 344: 158–160
   PubMed Web of Science ®Google Scholar
• Boehm T., Foroni L., Kaneko Y., Perutz M. F., Rabbitts T. H. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11 pi5 and 11p13. Proc. Natl. Acad. Sci. USA 1991; 88: 4367–4371
   PubMed Web of Science ®Google Scholar
• Royer-Pokora B., Loos U., Ludwig W.-D. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukemia with the t(11;14)(p13;q11). Oncogene 1991; 6: 1887–1893
   PubMed Web of Science ®Google Scholar
• Mellentin J. D., Murre C., Dolon T. A., McGaw P. S., Smith S. D., Carroll A. J., McDonald M. E., Baltimore D., Cleary M. L. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 1989; 246: 379–382
   PubMed Web of Science ®Google Scholar
• Nourse J., Mellentin J. D., Galili N., Wilkinson J., Stanbridge E., Smith S. D., Cleary M. L. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990; 60: 535–545
   PubMed Web of Science ®Google Scholar
• Kamps M. P., Murre C., Sun X.-H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547–555
   PubMed Web of Science ®Google Scholar
• Kamps M. P., Look A. T., Baltimore D. Human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbxl fusion proteins with differing transforming potentials. Genes. Dev 1991; 5: 358–368
   PubMed Web of Science ®Google Scholar
• Clark S. S., McLaughlin J., Crist W. M., Champlin R., Witte O. N. Unique forms of the abl tyrosine kinase distinguish Ph1-positiveCML from Ph1-positive ALL. Science 1987; 235: 85–87
   PubMed Web of Science ®Google Scholar
• Chan L. C., Karhi K. K., Rayter S. I., Heisterkamp N., Eridani S., Powles R., Lawler S. D., Groffen J., Foulkes J. G., Greaves M. F., Wiedemann L. W. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukemia. Nature 1987; 325: 635–637
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Shtalrid M., Romero P., Kloetzer W. S., Talpas M., Trujillo J. M., Blick M., Beran M., Gutterman J. U. A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 1987; 325: 631–635
   PubMed Web of Science ®Google Scholar
• Hermans A., Heisterkamp N., von Lindern M., van Baal S., Meijer D., van der Plas D., Wiedemann L. M., Groffen J., Bootsma D., Grosveld G. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 1987; 51: 33–40
   PubMed Web of Science ®Google Scholar
• Clark S. S., McLaughlin J., Timmons M., Pendergast A. M., Ben-Neriah Y., Dow L. W., Crist W., Rovera G., Smith S. D., Witte O. N. Expression of a distinctive bcr-abl oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 1988; 239: 775–777
   PubMed Web of Science ®Google Scholar
• Daley G. Q., van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210bcr/abi geng of the Philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Lugo T. G., Pendergast A.-M., Muller A. J., Witte O. N. Tyrosine kinase and transformation potency of bcr-abl oncogene products. Science 1990; 247: 1079–1082
   PubMed Web of Science ®Google Scholar
• Diaz M. O., Ziemins S., Le Beau M. M., Pitha P., Smith S. D., Chilcote R. R., Rowley J. D. Homozygous deletion of the ã and β interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 1988; 85: 5259–5263
   PubMed Web of Science ®Google Scholar
• Diaz M. O., Rubin C. M., Harden A., Ziemin S., Larson R. A., Le Beau M. M., Rowley J. D. Deletions of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med. 1990; 77–82
   PubMed Web of Science ®Google Scholar
• Einhorn S., Grander D., Björk O., Brödum-Nielsen K., Soderhall S. Deletion of ã-, β- and ω-Interferon genes in malignant cells from children with acute lymphocytic leukemia. Cancer Res. 1990; 50: 7781–7785
   PubMed Web of Science ®Google Scholar
• Chen Y., Chen P.-J., Yeh S.-H., Tien H.-F., Wang C.-H., Tang J.-L., Hong R.-L. Deletion of the human retinoblastoma gene in primary leukemias. Blood 1990; 76: 2060–2064
   PubMed Web of Science ®Google Scholar
• Ginsberg A. M., Raffeld M., Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991; 77: 833–840
   PubMed Web of Science ®Google Scholar
• Sugimoto K., Toyoshima H., Sakai R., Miyagawa K., Hagiwara K., Hirai H., Ishikawa F., Takaku F. Mutations of the p53 gene in lymphoid leukemia. Blood 1991; 77: 1153–1156
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Blume K. G. The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 1991; 78: 255–258
   PubMed Web of Science ®Google Scholar
• Gehly G. B., Bryant E. M., Lee A. M., Kidd P. G., Thomas E. D. Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1991; 78: 458–465
   PubMed Web of Science ®Google Scholar
• Hunger S. P., Galili N., Carroll A. J., Crist W. M., Link M. P., Cleary M. L. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 1991; 77: 687–693
   PubMed Web of Science ®Google Scholar
• Maurer J., Janssen J. W. G., Thiel E., van Denderen J., Ludwig W., Aydemir Ü., Heinze B., Fonatsch C., Harbott J., Reiter A., Riehm H., Hoelzer D., Bartram C. R. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 1055–1058
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Williams D. L., Kalwinsky D. K., Look A. T., Melvin S. L., Dodge R. K., Rivera G., Murphy S. B., Dahl G. V. Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia. Blood 1986; 67: 1688–1692
   PubMed Web of Science ®Google Scholar
• Privitera E., Kamps M. P., Hayashi Y., Inaba T., Shapiro L. H., Raimondi S. C., Behm F., Hendershot L., Carroll A. J., Baltimore D., Look A. T. Different molecular consequences of the 1:19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood, in press
   Google Scholar
• Ribeiro R. C., Abromowitch M., Raimondi S. C., Murphy S. B., Behm F., Williams D. L. Clinical and biological hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 1987; 70: 948–953
   PubMed Web of Science ®Google Scholar
• Berger R, Chen S. J., Chen Z. Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects. Cancer Genet. Cytogenet. 1990; 44: 143–152
   PubMed Web of Science ®Google Scholar
• Nowell P. C., Hungerford D. A. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497
   Web of Science ®Google Scholar
• Catovsky D. Philadelphia chromosome-positive acute leukaemia and chronic granulocytic leukaemia: one or two diseases?. Br. J. Haematol. 1979; 42: 493–498
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stephenson J. R., Groffen J., Hansen P. F., de Klein A., Bartram C. R., Grosveld G. Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukaemia. Nature 1983; 306: 239–242
   PubMed Web of Science ®Google Scholar
• Leibowitz D., Schaefer-Rego K., Popenoe D. W., Maers J. G., Bank A. Variable breakpoints on the Philadelphia chromosome in chronic myelogenous leukemia. Blood 1985; 66: 243–245
   PubMed Web of Science ®Google Scholar
• Gale R. P., Goldman J. M. Rapid progress in chronic myelogenous leukemia. Leukemia 1988; 2: 321–322
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Gutterman J. U., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 1988; 319: 990–998
   PubMed Web of Science ®Google Scholar
• Groffen J., Stephenson J. P., Heisterkamp N., de Klein A., Bartram C. R., Grosveld G. Philadelphia chromosome breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Stam K., Heisterkamp N., Reynolds F. H., Jr, Groffen J. Evidence that the phi gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. Mot. Cell. Biol. 1987; 7: 1955–1960
   Web of Science ®Google Scholar
• Konopka J. B., Watanabe S. M., Singer J. W., Collins S. J., Witte O. N. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc. Natl. Acad. Sci. USA 1985; 82: 1810–1814
   PubMed Web of Science ®Google Scholar
• Naldini L., Stacchini A., Cirillo D. M., Aglietta M., Gavosto F., Comoglo P. M. Phosphotyrosine antibodies identify the P210c-abl tyrosine kinase and proteins phosphory-lated on tyrosine in human chronic myelogenous leukemia cells. Mol. Cell. Biol. 1986; 6: 1803–1811
   PubMed Web of Science ®Google Scholar
• Hooberman A. L., Westbrook C. A. Molecular diagnosis of the Philadelphia chromosome in acute lymphoblastic leukemia. Leukemia and Lymphoma 1989; 1: 3–10
   PubMedGoogle Scholar
• Tachibana N., Raimondi S. C., Lauer S. J., Sartain P., Dow L. W. Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1987; 70: 1458–1461
   PubMed Web of Science ®Google Scholar
• Fletcher J. A., Lynch E. A., Kimball V. M., Donnelly M., Tantravahi R., Sallan S. E. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77: 435–439
   PubMed Web of Science ®Google Scholar
• Russo C, Carroll A., Kohler S., Borowitz M., Amylon M., Homans A., Kedar A., Shuster J., Land V., Crist W., Pullen J., Link M. Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1991; 11: 1050–1056
   Google Scholar
• Forman S. J., O'Donnell M. R., Nademanee A. P., Snyder D. S., Bierman P. J., Schmidt G. M., Fahey J. L., Stein A. S., Parker P. M., Blume K. G. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1987; 70: 587–588
   PubMed Web of Science ®Google Scholar
• Vernant J. P., Marit G., Maraninchi D., Guyotat D., Kuentz M., Cordonnier C., Reiffers J. Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission. J. Clin. Oncol. 1988; 6: 227–231
   PubMed Web of Science ®Google Scholar
• Dow L. W., Tachibana N., Raimondi S. C., Lauer S. J., Witte O. N., Clark S. C. Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q11 variants. Blood 1989; 73: 1291–1297
   PubMed Web of Science ®Google Scholar
• Patte C, Philip T., Rodary C., Bernard A, Zucker J.-M., Bernard J.-L., Robert A., Rialland X., Benz-Lemoine E., Demeocq F., Bayle C., Lemerle J. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J. Clin. Oncol. 1986; 4: 1219–1226
   PubMed Web of Science ®Google Scholar
• Berger R., Bernheim A. Cytogenetic studies on Burkitt's lymphoma-leukemia. Cancer Genet. Cytoaenet. 1982; 7: 231–244
   PubMed Web of Science ®Google Scholar
• Rowley J. D., Variakojis D., Kaneko Y., Cimino M. A Burkitt-lymphoma variant translocation (2p -;8q +) in patients with ALL, L3 (Burkitt type). Hum. Genet. 1981; 58: 166–167
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Rowley J. D., Check I., Variakojis D., Moohr J. W. The 14q+ chromosome in pre-B ALL. Blood 1980; 56: 782–785
   PubMed Web of Science ®Google Scholar
• Mufti G. J., Hamblin T. J., Oscier D. G., Johnson S. Common ALL with pre-B-cell features showing (8; 14) and (14; 18)chromosome translocations. Bloodf 1983; 62: 1142–1146
   PubMed Web of Science ®Google Scholar
• Mangan K. F., Rauch A. E., Bishop M., Spiers A. S., Lorch C., Scharfman W. B. Acute lymphoblastic leukemia of Burkitt's type (L-3 ALL) lacking surface immonuglobulin and the 8; 14 translocation. Am. J. Clin. Pathol. 1985; 83: 121–126
   PubMed Web of Science ®Google Scholar
• Solomons H. D., Mendelow B., Levinstein A., Johnson A. E., Bernstein R. Burkitt cell leukemia with abnormality of chromosome No. 1. Am. J. Hemalol. 1983; 14: 297–300
   PubMed Web of Science ®Google Scholar
• Imamura N., Mtasiwa D. M., Ota H, Inada T., Kuramoto A. FAB L3 type of B-cell acute lymphoblastic leukemia (B-ALL) without chromosome abnormalities. Am. J. Heamatol. 1990; 35: 216–218
   PubMed Web of Science ®Google Scholar
• Hann L., Morris-Jones P., Eden O. E., Barnes J. Improved prognosis of B-ALL with a high dose schedule (MACHO). Med. Pediatr. Oncol. 1988; 16: 422, (bstr.)
   Google Scholar
• Feickert H., Ubel U., Ludwig W., Müller-Weihrich S., Ritter J., Riehm H. Childhood acute lymphoblastic leukemia of B-cell type: trials ALL-BFM 81 and ALL-BFM 83. Proc. ASCO 1987; 6: 149, (abstr)
   Google Scholar
• Patte G, Philip T., Rodary C., Zucker J.-M., Behrendt H., Gentet J., Lamagnére J.-P., Otten J., Dufillot D., Pein F., Caillou B., Lemerle J. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatic Oncology Society of a randomized trial of 216 children. J. Clin. Oncol. 1991; 9: 123–132
   PubMed Web of Science ®Google Scholar
• Ribeiro R. C., Raimondi S. C., Behm F. G., Cherrie J., Crist W. M., Pui C.-H. Clinical and biologic features of childhood T-cell leukemia with the t(11;14). Blood 1991; 78: 466–470
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Frizzera G., Shikano T., Kobayashi H., Maseki N., Sakurai M. Chromosomal and immunopheno-typic patterns in T-cell acute lymphoblastic leukemia (T ALL) and lymphoblastic lymphoma (LBL). Leukemia 1989; 3: 886–892
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Frankel L. S., Carroll A. J., Raimondi S. C., Shuster J. J., Head D. R., Crist W. M., Land V. J., Pullen D. J., Steuber C. P., Behm F. G., Borowitz M. J. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;l 1)(q21;q23): a collaborative study of 40 cases. Blood 1991; 11: 440–447
   Google Scholar
• Pui C.-H. Acute leukemia with the t(4;11)(q21;q23). Leukemia and Lymphoma 1991, in press
   Google Scholar
• Ferro M. T., San Roman C, Muñoz A., Madero L., Olmeda F., Fernández-Rãnada J. M., Mecucci C. Translocation (4; 11) in ALL: a new morphologic aspect?. Cancer Genel. Cytogenet. 1986; 23: 145–149
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Francies di Celle P., Alimena G., De Rossi G., Gastaldi R., Casorati G., Saglio G., Foa R. Acute lymphoblastic leukemia with the 4; 11 translocation exhibiting early T-cell features. Leukemia 1989; 3: 79–82
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Behm F. G., Singh B., Rivera G. K., Schell M. J., Roberts W. M., Mirro W. M., Crist J., Jr. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 15: 198–202
   Google Scholar
• Pui C.-H., Hancock M. L., Crist W. M. Prognosis in children with the t(4;11)(q21;q23) acute leukemia. Blood, 78: 2472–2473, response to letter
   Web of Science ®Google Scholar
• Nagasaka M., Maeda S., Maeda H., Chen H.-L., Kita K., Mabuchi O., Misu H., Matsuo T., Sugiyama T. Four cases of t(4; 11) acute leukemia and its myelomonocytic nature in infants. Blood 1983; 61: 1174–1181
   PubMed Web of Science ®Google Scholar
• Stong R. C., Kersey J. H. In vitro culture of leukemic cells in t(4; 11) acute leukemia. Blood 1985; 66: 439–443
   PubMed Web of Science ®Google Scholar
• Srivastava B. I. S., Wright J. J., Bakhshi A. O. Immunoglobulin chain gene rearrangements in a t(4; 11) acute leukemia with monocytoid blasts. Br. J. Haematol. 1986; 63: 321–329
   PubMed Web of Science ®Google Scholar
• Léglise M., Rivière D., Le Calvez G., Le Bris M., Sensebé L., Brierè J. In vitro study of translocation t(4;11) acute leukemia. Sequential range of phenotype. Arch. Pathol. Lab. Med. 1989; 113: 164–168
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Peiper S. C., Kitchingman G. R., Behm F. G., Williams D. L., Hancock M. L., Hancock J., Jr. Childhood acute lymphoblastic leukemia with chromosomal breakpoints at 11q23. Blood 1989; 73: 1627–1634
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Kobayashi Y., Hirai H., Hanada R., Yamamoto K., Abe T., Sugita K., Nakazawa S., Suetake N., Hoshino H., Kuroume T., Bessho F., Hayakawa H., Takaku F. Immunoglobulin heavy chain gene rearrangements and mixed lineage characteristics in acute leukemias with the 11; 19 translocation. Cancer 1988; 61: 712–720
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Maseki N., Takasaki N., Sakurai, Hayashi M., Nakazawa S., Mori T., Sakurai M., Takeda T., Shikano T., Hiyoshi Y. Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. Blood 1986; 67: 484–491
   PubMed Web of Science ®Google Scholar
• Hudson M. M., Raimondi S. C., Behm F. G., Pui C.-H. Phenotypic and karyotypic changes in childhood acute leukemia with t(11;19Xq23;p13). Leukemia, in press
   Google Scholar
• Carroll A. J., Raimondi S. C., Williams D. L., Behm F. G., Borowitz M., Castleberry R. P., Harris M. B., Patterson R. B., Pullen D. J., Crist W. M. tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: A Pediatric Oncology Group Study. Blood 1987; 70: 1962–1965
   PubMed Web of Science ®Google Scholar
• Huret J. L., Heerema N. A., Brizard A., Provisor A. J., Benz-Lemoine E., Guilhot F., Savage J. R., Tanzer J. Two additional cases of tdic(9;12) in acute lymphocytic leukemia (ALL): prognosis in ALL with dic(9; 12). Leukemia 1990; 4: 423–425
   PubMed Web of Science ®Google Scholar
• Mahmoud H., Carroll A. J., Behm F., Raimondi S. C., Shuster J., Borowitz M., Land V., Pullen D. J., Vietti T. J., Crist W. The nonrandom dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis
   Google Scholar
• Hogan T. F., Koss W., Murgo A. J., Amato R. S., Fontana J. A., Van Scoy F. L. Acute lymphoblastic leukemia with chromosomal 5; 14 translocation and hypereosinophilia: case report and literature review. J. Clin. Oncol. 1987; 5: 382–390
   PubMed Web of Science ®Google Scholar
• Grimaldi J. C., Meeker T. C. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood 1989; 13: 2081–2085
   Google Scholar
• Chilcote R. R., Brown E., Rowley J. D. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N. Engl. J. Med. 1985; 313: 286–291
   PubMed Web of Science ®Google Scholar
• Smith S. D., Link M. P., Trela M., Amylon M., Sklar J., Morgan R., Hecht F. Chromosome 9 abnormalities in childhood T-cell leukemia. N. Engl. J. Med. 1986; 315: 195, (letter)
   PubMed Web of Science ®Google Scholar
• Carroll A. J., Castleberry R. P., Crist W. H. Lack of association between abnormalities of the chromosome 9 short arm and either “lymphomatous” features or T-cell phenotype in childhood acute lymphocytic leukemia. Blood 1987; 69: 735–738
   PubMed Web of Science ®Google Scholar
• Murphy S. B., Raimondi S. C., Rivera G. K., Crone M., Dodge R. K., Behm F. G., Pui C.-H., Williams D. L. Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood 1989; 74: 409–415
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Williams D. L., Callihan T., Peiper S., Rivera G. K., Murphy S. B. Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986; 68: 69–75
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Raimondi S. C., Look A. T., Behm F. G., Kitchingman G. R., Pui C.-H., Rivera G. K., Williams D. L. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1626–1630
   PubMed Web of Science ®Google Scholar
• Mirro J., Zipf T. F., Pui C.-H., Kitchingham G., Williams D., Melvin S., Murphy S. B., Stass S. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood 1985; 66: 1115–1123
   PubMed Web of Science ®Google Scholar
• Chessells J., Janossy G., Lawler S. D., Seeker-Walker L. M. The Ph1 chromosome in childhood leukemia. Br. J. Haematol. 1979; 41: 25–41
   PubMed Web of Science ®Google Scholar
• Hirsch-Ginsberg C, Childs C, Chang K., Beran M., Cork A., Reuben J., Freireich E. J., Chang L. C. M., Bollum F. J., Trujillo J., Stass S. A. Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. Blood 1988; 71: 186–195
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Sugita K., Nakazawa S., Abe T., Kojima S., Inaba T., Hanada R., Yamamoto K. Karyotypic patterns in acute mixed-lineage leukemia. Leukemia 1990; 4: 121–126
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Head D. R., Schell M. J., Rivera G. K., Mirro J., Jr, Crist W. M., Behm F. G. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 1991; 78: 1327–1337
   PubMed Web of Science ®Google Scholar
• Parkin J. L., Arthur D. C., Abramson C. S., McKenna R. W, Kersey J. H., Heideman R. L., Brunning R. D. Acute leukemia associated with the t(4;11) chromosome rearrangement: ultrastructural and immunologic chracteris-tics. Blood 1982; 60: 1321–1331
   PubMed Web of Science ®Google Scholar
• Crist W. M., Cleary M. L., Grossi C. E., Prasthofer E. F., Heggie G. D., Omura G. A., Carroll A. J., Link M. P., Sklar J. Acute leukemias associated with the 4; 11 chromosomal translocation have rearranged immunoglobulin heavy chain genes. Blood 1985; 66: 33–38
   PubMed Web of Science ®Google Scholar
• Childs C. C., Hirsch-Ginsberg C., Culbert S. J., Ahearn M, Reuben J., Trujillo J. M., Cork A., Walters R. R., Freireich E. J., Stass A. A. Lineage heterogeneity in acute leukemia with the t(4;11) abnormality: implications of acute mixed lineage leukemia. Hemalol. Pathol. 1988; 2: 145–157
   PubMedGoogle Scholar
• Hayashi Y., Pui C.-H., BehmFuchs F. G., Raimondi S. C., Kitchingman G. R., Mirro J., Jr, Williams D. L. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia. Blood 1990; 16: 150–156
   Google Scholar
• Pui C., Raimondi M. J., Head D. R., Rivera G. K., Crist W. M., Behm F. G. Myeloid-antigen expression in childhood acute lymphoblastic leukemia. N. Engl. J. Med. 1991; 325: 1378–1379
   PubMed Web of Science ®Google Scholar
• Williams D. L., Raimondi S. C., Rivera G. Most cases of acute lyphoblastic leukemia (ALL) undergo marked karyotypic shift from diagnosis to relapse. Blood 1984; 64(suppl 1)208a
   Google Scholar
• Kowalczyk J. R., Grossi M., Sandberg A. A. Cytogenetic findings in childhood acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 1985; 15: 47–64
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L. M., Alimena G., Bloomfield C. D., Kaneko Y, Peng J., Arthur D. C., de la Chapelle A., Reeves B. R., Rowley J. D., Lawler S. D., Mitelman F. Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse. Cancer Genet. Cytogenet. 1989; 40: 163–169
   PubMed Web of Science ®Google Scholar
• Shikano T., Ishikawa Y., Ohkawa M., Hatayama Y., Nakadate H., Hatae Y., Takeda T. Karyotypic changes from initial diagnosis to relapse in childhood acute leukemia. Leukemia 1990; 4: 419–422
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Raimondi S. C., Behm F. G., Ochs J., Furman W. L., Bunin N. J., Ribeiro R. C., Tinsley P. A., Mirro J. Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia. Blood 1986; 68: 1306–1310
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Behm F. G., Raimondi S. C., Dodge R. K., George S. L., Rivera G. K., Mirro J., Jr, Kalwinsky D. K., Dahl G. V., Murphy S. B., Crist W. M., Williams D. L. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N. Engl. J. Med. 1989; 321: 136–142
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Jacobson R. J., Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 1977; 63: 125–130
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Burke P. J., Schiffer C. A., Zehnbauer B. A., Vogelstein B. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute non-lymphocytic leukemia. N. Engl. J. Med. 1986; 315: 15–24
   PubMed Web of Science ®Google Scholar
• Pui C.-H, Raskind W. H., Kitchingman G. R., Raimondi S. C., Behm F. G., Murphy S. B., Crist W. M., Fmlkow P. J., Williams D. L. Clonal analysis of childhood acute lymphoblastic leukemia with “cytogenetically independent” cell populations. J. Clin. Invest. 1989; 83: 1971–1977
   PubMed Web of Science ®Google Scholar
• Ratain M. J., Kaminer L. S., Bitran J. D., Larson R. A., LeBeau M. M., Skosey C., Purl S., Hoffman P. C., Wade J., Vardiman J. W., Daly K., Rowley J. D., Golomb H. M. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 1987; 70: 1412–1417
   PubMed Web of Science ®Google Scholar
• De Vore R., Whitlock J., Hainsworth J. D., Johnson D. H. Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome llq. Ann. Intern. Med. 1989; 110: 740–742
   PubMedGoogle Scholar
• Pui C.-H., Hancock M. L., Raimondi S. C., Head D. R., Thompson E., Wilimas J., Kun L. E., Bowman L. C., Crist W. M., Pratt C. B. Myeloid neoplasia in children treated for solid tumors. Lancet 1990; 336: 417–421
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Philip P., Larsen S. O., Jensen G., Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 76: 1083–1091
   PubMed Web of Science ®Google Scholar
• Pui C.-H. Therapy-related myeloid leukemia. Lancet 1990; 336: 1130–1131
   PubMed Web of Science ®Google Scholar
• Prieto F., Palau F., Badia L., Beneyto, Perez M., Sirvent M. L., Orts A., Castle V. 11q23 abnormalities in children with acute nonlymphocytic leukemia (M4-M5): association with previous chemotherapy. Cancer Genet. Cytogenet. 1990; 45: 1–11
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Daugaard G., Werner Hansen S., Philip P., Olesen Larsen S., Rørth M. Increased risk of myelodysplasia and leukemia after etoposide, cisplatin. and bleomycin for germ-cell tumours. Lancet 1991; 338: 359–363
   PubMed Web of Science ®Google Scholar
• Pratt G. B., Pui C.-H. Second tumors after treatment with anticancer drugs. The Toxicity of Anticancer Drugs, G. Powis, M. P. Hacker. Pergamon Press, New York 1991; 28–43
   Google Scholar
• Pedersen-Bjergaard J., Philip P. Balanced translocations involving chromsome bands 11q23 and 21q22 are highly characteristic for myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood 1991; 78: 1147–1148
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Ribeiro R. C., Hancock M. L., Rivera G. K., Evans W. E., Raimondi S. C., Head D. R., Behm F. G., Mahmoud M. H., Sandlund J. T., Crist W. M. Acute myeloid leukemia in children treated with epipo-dophyllotoxins for acute lymphoblastic leukemia. N. Engl. J. Med. 1991; 325: 1682–1687
   PubMed Web of Science ®Google Scholar